ArticleInternational journal of hematology2020

Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma.

Syahrul Chilmi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.